![]() |
市場調查報告書
商品編碼
1789946
醫藥物流市場規模、佔有率和趨勢分析報告:按類型、組成部分、地區和細分市場預測,2025 年至 2033 年Pharmaceutical Logistics Market Size, Share & Trends Analysis Report By Type (Cold Chain Logistics, Non-cold Chain Logistics), By Component (Storage (Warehouse, Refrigerator Containers), Transportation), By Region, And Segment Forecasts, 2025 - 2033 |
醫學物流市場概覽
2024 年全球醫藥物流市場價值估計為 993.3 億美元,預計到 2033 年將達到 2,082.6 億美元,2025 年至 2033 年的複合年成長率為 8.5%。醫藥物流市場受到對溫度敏感藥物和生技藥品的需求不斷成長、全球醫藥貿易不斷成長以及醫療保健電子商務擴張的推動。
低溫運輸物流的進步、藥品安全監管要求的嚴格以及追蹤技術的日益普及,進一步推動了市場的成長。此外,慢性病的日益普及以及對及時安全配送藥品(包括疫苗和特殊藥品)的需求,也推動了醫藥產業對專業物流服務的依賴程度的提高。隨著上述疫苗核准使用,主要疫苗製造商正在積極考慮在全球分銷這些疫苗。確保全球範圍內緊急使用疫苗需要一條韌性十足的供應鏈,預計這將在預測期內顯著推動市場成長。
此外,用於治療感染疾病(COVID-19) 的藥物需求也有望推動市場成長。市場成長也歸因於對非處方藥 (OTC) 的需求不斷成長,例如維生素、礦物質和補充劑 (VMS)、常見的咳嗽和感冒藥、胃腸道藥物以及皮膚科產品。醫療保健領域對快速援助日益成長的重要性也推動了醫藥物流市場的發展。此外,透過建立單一分銷管道來降低分銷成本也進一步推動了醫藥物流的需求。
許多公司正在進行併購,以擴大其地理覆蓋範圍和專有知識。他們也致力於降低產品的整體包裝成本。生物成分和藥品的供應鏈尤其容易受到運輸過程中產品摻假以及不遵守聯邦法規、標準和指南的風險的影響。因此,企業正在積極投資遠端資訊處理和遠端監控等最尖端科技,以提供運輸過程中的安全性和便利性,從而推動市場成長。
製藥商擴大委託標籤和包裝業務外包給第三方供應商。許多製藥公司正在向拉丁美洲和撒哈拉以南非洲等服務不足的地區擴張。對於製藥商而言,選擇擁有強大製藥專業知識的本地物流供應商至關重要。然而,服務水準低落和失控是外包業務面臨的主要威脅。
在美國,由於學名藥的改革,對學名藥物流的需求不斷成長。北美的醫藥物流市場高度分散,由多家區域性和國際性公司組成。眾多區域性和全球性公司的存在使得該行業競爭激烈。
領先的公司正致力於提供雲端基礎的供應鏈解決方案和安全的供應鏈能力。這些解決方案可以防止假藥和醫療設備的生產。預計海運和空運醫藥物流需求的不斷成長將在預測期內推動產業成長。海運藥品可降低高達 80.0% 的運輸成本,並減少所需人員。
此外,這種先進的包裝有助於最佳化包裝和儲存要求,同時最大限度地減少物流業務的碳排放。高價值藥品和疫苗的遠距和洲際運輸對航空貨運物流的依賴日益增加,預計也將進一步推動市場成長。
Pharmaceutical Logistics Market Summary
The global pharmaceutical logistics market size was estimated at USD 99.33 billion in 2024 and is projected to reach USD 208.26 billion in 2033, growing at a CAGR of 8.5% from 2025 to 2033. The pharmaceutical logistics market is driven by the growing demand for temperature-sensitive drugs and biologics, rising global pharmaceutical trade, and the expansion of e-commerce in healthcare.
Advancements in cold chain logistics, stringent regulatory requirements for drug safety, and increasing adoption of track-and-trace technologies further propel market growth. Additionally, the rising prevalence of chronic diseases and the need for timely and secure delivery of medications, including vaccines and specialty drugs, are contributing to the increased reliance on specialized logistics services in the pharmaceutical sector. With the approval of the aforementioned vaccines for usage, key vaccine producers are actively looking to distribute these vaccines around the globe. It would need a resilient supply chain to make vaccines available across the globe for urgent usage. Therefore, it is estimated to drive the growth of the market at a significant pace during the forecast period.
Along with this, the demand for medicines used for curing the novel coronavirus disease is also expected to boost the market growth. The growth of the market is also attributed to the increasing demand for Over-the-Counter (OTC) medicines such as Vitamins, Minerals, and Supplements (VMS), common cough and cold drugs, gastrointestinal drugs, and dermatology products. The rising importance of fast-track assistance in the healthcare sector is also driving the market for pharmaceutical logistics. Moreover, decreasing the distribution cost by creating a single source distribution channel further increases the demand for pharmaceutical logistics.
Many companies are entering into mergers and acquisitions to expand their geographical presence and proprietary knowledge. They are also focusing on reducing the overall packaging costs of their products. The biocomponent and pharmaceutical supply chains are particularly prone to the risks associated with product adulteration during transport as well as non-compliance with federal regulations, standards, and guidelines. As a result, the players are actively investing in state-of-the-art technologies such as telematics and remote monitoring to provide safety and convenience during transportation operations, which is, in turn, propelling the market growth.
Pharmaceutical manufacturing companies are increasingly outsourcing labeling and packaging activities to third-party providers. Many pharmaceutical companies are expanding their operations in untapped regions, including Latin America and Sub-Saharan Africa. The preference for local logistics providers with high expertise in pharmaceuticals is of great importance to drug manufacturers. However, deteriorating service levels and loss of control are significant threats that are faced in outsourcing operations.
The demand for pharmaceutical logistics is growing in the U.S. due to increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics. The market for pharmaceutical logistics in North America is significantly fragmented, owing to several regional and international companies. The industry is highly competitive due to the presence of many local and global companies.
Major companies strive to offer cloud-based supply chain solutions and secure supply chain functions, as it helps manufacturers ensure the authenticity of the drugs. These solutions prevent the production of counterfeit drugs and medical devices. The increasing demand for sea and air freight pharmaceutical logistics is anticipated to propel industry growth during the forecast period. The transportation of pharma products by sea reduces the transportation cost by up to 80.0% and decreases the staffing requirements.
In addition, these advancements help optimize packaging and storage requirements while minimizing the carbon footprint of logistics operations. The growing reliance on air freight logistics for the long-distance and intercontinental transport of high-value medicines and vaccines is also anticipated to further drive market growth.
Global Pharmaceutical Logistics Market Report Segmentation
The report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical logistics market report based on type, component, and region: